Heart Disease News and Research

Latest Heart Disease News and Research

Mount Sinai study connects social determinants of health to disease risks

A new study from the Icahn School of Medicine at Mount Sinai shows that social determinants of health-including environmental conditions, health behaviors, access to resources, and social well-being-can play an equally important or even greater role than genetics in predicting a person's risk of developing common diseases.

22 Jun 2026

Sugary drinks from childhood linked to adult hypertension risk

Drinking fruit juice and sugar-sweetened beverages from childhood through adulthood may be linked to an increased risk of developing high blood pressure as an adult, according to new research published today in the American Heart Association's flagship journal Circulation.

22 Jun 2026

International survey highlights major gaps in cardio-oncology education

An international survey has highlighted major gaps in cardio-oncology training, despite its increasing clinical importance. These results were presented at ESC Cardio-Oncology 2026, the second annual conference of the European Society of Cardiology's Council of Cardio-Oncology.

21 Jun 2026

Estradiol changes may shape how much women move during the menstrual cycle

A 28-day wearable-sensor study of 26 healthy naturally menstruating women found that active energy expenditure varied across the menstrual cycle and was higher in the early follicular phase than the late follicular phase.

21 Jun 2026

Heart failure treatments protect heart function during cancer therapy

The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ESC Cardio-Oncology 2026, the annual conference of the European Society of Cardiology's Council of Cardio-Oncology.

19 Jun 2026

PMOS rethink reframes a common hormone disorder as a whole-body disease

A new review reframes PCOS, now proposed as PMOS, as a systemic endocrine and metabolic disorder shaped by genetic, epigenetic, ovarian, metabolic, and neuroendocrine pathways. It highlights why inconsistent diagnosis and symptom-focused care have limited progress, while targeted therapies, biomarkers, machine learning, and organ-on-chip models may support more personalized treatment.

18 Jun 2026

New biological age tools could reveal health risks before symptoms appear

A JCI review traces biological age measurement from functional tests and blood biomarkers to epigenetic, proteomic, imaging, wearable, and AI-based clocks. It finds that these tools can improve risk prediction beyond chronological age, but standardization, interpretability, and prospective validation are needed before routine clinical use.

18 Jun 2026

Neurological disorders may raise traumatic brain injury risk in older adults

For traumatic brain injury (TBI) and certain brain diseases, it looks like the risk may go in both directions, according to a study published on June 17, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

17 Jun 2026

Digital heart twins could improve atrial fibrillation treatment planning

A cross-University paper led by researchers at Queen Mary University of London, published in the Journal of Physiology shows how better 'digital twins' could help doctors treating people with Atrial Fibrillation.

17 Jun 2026

Onion-loving gene linked to lower diabetes and blood pressure risk

Imagine if a doctor could look at your DNA and predict not just your disease risk, but also which foods you're drawn to – and whether those cravings are quietly protecting you.

17 Jun 2026

AI-designed drug for Parkinson's begins first human trial

Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced it has achieved the first clinical milestone in its co-development collaboration with Hygtia Therapeutics with the completion of first-in-human dosing in the Phase I study of ISM8969.

17 Jun 2026

Novel gene therapy appears to be safe for Friedreich ataxia cardiomyopathy

A new gene therapy appears to be safe in patients diagnosed with Friedreich ataxia cardiomyopathy, a progressive and fatal inherited cardiac disease, according to a phase 1 clinical trial led by Weill Cornell Medicine researchers.

17 Jun 2026

Resistance training reduces major heart disease risk for active women

Women who lift weights may have a lower risk of major heart disease, especially when combined with aerobic exercise, according to a new study published today in JACC, the flagship journal of the American College of Cardiology.

17 Jun 2026

Smartphone apps and wearables help heart disease patients stay active

Smartphone apps, fitness trackers and wearable devices help people with heart disease get more physical activity in their daily lives, according to an analysis of previous research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

17 Jun 2026

New protein discovery could lead to safer antithrombotic therapies

Antiplatelet drugs are one of the main tools used to prevent thrombus formation in people who have had a heart attack or stroke or who have cardiovascular diseases with a high thrombotic risk.

17 Jun 2026

Losing smell and taste may profoundly affect wellbeing

University of East Anglia research reveals that smell loss can affect quality of life as severely as conditions including diabetes, stroke, Parkinson's, and kidney failure.

16 Jun 2026

New AI model protects patient privacy in ECG data

A common misperception exists that electrocardiograms (ECGs) simply contain data about heart activity.

16 Jun 2026

Heart tissue repair drug may also help repair and regenerate damaged kidney tissues

A drug previously developed at UCLA to help heart tissue repair itself after a heart attack might also help kidney tissue repair and regenerate, researchers have found.

16 Jun 2026

Lysosomal protein stabilizes mitochondria to prevent severe heart failure

A new study published in Engineering has uncovered a regulatory mechanism linking lysosomal function to mitochondrial stability in pathological cardiac hypertrophy, identifying transient receptor potential mucolipin 1 (TRPML1) as a key protective factor against the progression to heart failure.

16 Jun 2026

Real-time brain stimulation improves gait for Parkinson's patients

UC San Francisco researchers have developed a new form of deep brain stimulation (DBS) that adjusts in real time as a person walks, helping improve gait and reduce falls in people with Parkinson's disease.

16 Jun 2026